Evidence map›Paper›PMID 25741989›Full record

ArticleNature protocols2015

Focal embolic cerebral ischemia in the rat.

Li Zhang, Rui Lan Zhang, Quan Jiang, Guangliang Ding, Michael Chopp, Zheng Gang Zhang

Open access · greenAbstract read
In one paragraph

Article in Nature protocols, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 87 citations in OpenAlex.

  1. Review
  2. Cytoprotection Concepts for Ischemic Stroke in the Recanalization Era.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Optimized mouse model of embolic MCAO: From cerebral blood flow to neurological outcomes.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2022
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Animal models of stroke.Animal models and experimental medicine · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Li ZhangDepartment of Neurology, Henry Ford Hospital, Detroit, Michigan, USA.
Rui Lan ZhangDepartment of Neurology, Henry Ford Hospital, Detroit, Michigan, USA.
Quan JiangDepartment of Neurology, Henry Ford Hospital, Detroit, Michigan, USA.
Guangliang DingDepartment of Neurology, Henry Ford Hospital, Detroit, Michigan, USA.
Michael Chopp1] Department of Neurology, Henry Ford Hospital, Detroit, Michigan, USA. [2] Department of Physics, Oakland University, Rochester, Michigan, USA.
Zheng Gang ZhangDepartment of Neurology, Henry Ford Hospital, Detroit, Michigan, USA.
Henry Ford Hospital · USOakland University · US

Funding

Ac-SDKP for Treatment of Acute StrokeR01NS079612 · NINDS · HENRY FORD HEALTH SYSTEM · PI ZHANG, ZHENG GANG · 2013 to 2017
$1.6M
MicroRNAs and neurogenesis after strokeR01NS075156 · NINDS · HENRY FORD HEALTH SYSTEM · PI ZHANG, ZHENG GANG · 2011 to 2015
$1.6M
MSCs Induce Brain Plasticity via tPAR01AG037506 · NIA · HENRY FORD HEALTH SYSTEM · PI CHOPP, MICHAEL · 2011 to 2015
$1.5M
NIA NIH HHS R01 AG037506NIA NIH HHS R01AG037506NINDS NIH HHS R01 NS075156NINDS NIH HHS R01 NS079612NINDS NIH HHS R01NS079612
6 · The paper itself

Abstract

Animal models of focal cerebral ischemia are well accepted for investigating the pathogenesis and potential treatment strategies for human stroke. Occlusion of the middle cerebral artery (MCA) with an endovascular filament is a widely used model to induce focal cerebral ischemia. However, this model is not amenable to thrombolytic therapies. As thrombolysis with recombinant tissue plasminogen activator (rtPA) is a standard of care within 4.5 h of human stroke onset, suitable animal models that mimic cellular and molecular mechanisms of thrombosis and thrombolysis of stroke are required. By occluding the MCA with a fibrin-rich allogeneic clot, we previously developed an embolic model of MCA occlusion in the rat, which recapitulates the key components of thrombotic development and of thrombolytic therapy of rtPA observed from human ischemic stroke. Here we describe in detail the surgical procedures of our model, including preparing emboli from rat donors. These procedures can be typically completed within ∼30 min, and they are highly adaptable to other strains of rats, as well as mice, in both sexes. Thus, this model provides a powerful tool for translational stroke research.

Indexed as

Disease Models, AnimalAnimalsBrain IschemiaInfarction, Middle Cerebral ArteryMaleMiddle Cerebral ArteryRats, WistarThrombolytic TherapyVascular Access Devices

Identifiers

PMID25741989
PMCPMC4602402
OpenAlexW2059657934

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.